IREN Limited - Ordinary Shares (IREN)
64.04
-3.80 (-5.60%)
NASDAQ· Last Trade: May 28th, 4:37 PM EDT
Detailed Quote
| Previous Close | 67.84 |
|---|---|
| Open | 66.54 |
| Bid | 64.15 |
| Ask | 64.21 |
| Day's Range | 63.55 - 66.75 |
| 52 Week Range | 8.280 - 76.87 |
| Volume | 46,328,439 |
| Market Cap | - |
| PE Ratio (TTM) | 48.52 |
| EPS (TTM) | 1.3 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 53,846,791 |
Chart
About IREN Limited - Ordinary Shares (IREN)
Iris Energy Limited is a renewable energy company that focuses on the development and operation of sustainable data centers powered primarily by green energy sources. The company engages in the mining of cryptocurrencies, leveraging its environmentally friendly infrastructure to provide a more sustainable alternative to traditional mining operations that often rely on fossil fuels. By utilizing renewable energy, Iris Energy aims to reduce the carbon footprint associated with cryptocurrency mining while fostering growth in the digital asset ecosystem. Read More
News & Press Releases
IREN is leveraging its massive grid-connected power assets in Texas to secure high-margin artificial intelligence contracts and transform its valuation.
Via MarketBeat · May 28, 2026
The computing infrastructure provider is helping its customers build AI factories faster.
Via The Motley Fool · May 27, 2026
There's increasing competition in nearly all parts of the AI space -- except for one.
Via The Motley Fool · May 27, 2026
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced it has entered into a purchase agreement with Dell for air-cooled Blackwell systems to service its previously announced five-year, $3.4bn managed services AI cloud contract.
By IREN · Via GlobeNewswire · May 26, 2026
IREN Limited (NASDAQ: IREN) stock continues to rally, climbing over 4% in premarket trading. Discover what is driving the upward surge.
Via Benzinga · May 26, 2026
Most people are ignoring these tech stocks, presenting a compelling opportunity for savvy investors.
Via The Motley Fool · May 26, 2026
Demand for Nvidia's AI chips keeps rising, but its stock portfolio can become a catalyst for future earnings.
Via The Motley Fool · May 25, 2026
Iren's newest deal could reshape the company's future, but after a 500% rally, investors need to decide whether this AI infrastructure stock is still early or already overheated.
Via The Motley Fool · May 25, 2026
Nvidia now has a financial incentive to help this emerging AI data center company succeed.
Via The Motley Fool · May 22, 2026
Keel Infrastructure is a smaller crypto miner that is pivoting to AI, and investors are missing out.
Via The Motley Fool · May 19, 2026
Nvidia has a track record of overachieving in its earnings reports.
Via The Motley Fool · May 18, 2026
The data center operator's latest spate of news items confirmed both its upside potential and its lingering risks.
Via The Motley Fool · May 18, 2026
NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced the acquisition of Awaken, a creative and media agency specializing in content strategy and brand development for high-growth companies.
By IREN · Via GlobeNewswire · May 18, 2026
This technology-driven insurer leverages data science and automation to streamline claims and attract digitally savvy policyholders.
Via The Motley Fool · May 17, 2026
Nvidia is well-positioned to continue shaping the future of artificial intelligence.
Via The Motley Fool · May 16, 2026
As AI infrastructure investment shifts beyond semiconductors, data center companies like Applied Digital, IREN, and CoreWeave are emerging as potential beneficiaries.
Via MarketBeat · May 15, 2026
Working with Nvidia represents this neocloud operator's second AI hyperscaler deal in the last year.
Via The Motley Fool · May 14, 2026
NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced the closing of its offering of $3.0 billion aggregate principal amount of 1.00% convertible senior notes due 2033 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).
By IREN · Via GlobeNewswire · May 14, 2026
IREN Limited (NASDAQ: IREN) stock surges on Thursday following the settlement of a $2.6 billion capital raise. Explore analyst views from Macquarie and JPMorgan.
Via Benzinga · May 14, 2026
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced the pricing of its offering of $2.6 billion aggregate principal amount of 1.00% convertible senior notes due 2033 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $2 billion aggregate principal amount of notes.
By IREN · Via GlobeNewswire · May 12, 2026
Today, May 11, 2026, investors are weighing fresh debt, an earnings miss, and a sprawling Nvidia-backed AI buildout.
Via The Motley Fool · May 11, 2026
IREN Ltd. (NASDAQ:IREN) shares face selling pressure this Monday.
Via Benzinga · May 11, 2026
NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced its intention to offer, subject to market and other conditions, $2 billion aggregate principal amount of convertible senior notes due 2033 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). IREN also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $300 million principal amount of notes.
By IREN · Via GlobeNewswire · May 11, 2026
Chips Up, Confidence Down: AI Demand Drives Friday's Rally Despite Record Consumer Pessimismchartmill.com
Via Chartmill · May 11, 2026
This biotech firm develops therapies for rare pulmonary diseases, leveraging proprietary drug delivery technology in the U.S. market.
Via The Motley Fool · May 9, 2026